𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Guest editorial: Neoadjuvant therapy, predictors of response, and patient outcomes

✍ Scribed by David Allen August; Christopher Gannon

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
43 KB
Volume
102
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Right ventricular dysfunction is a predi
Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy
✍ Francisco Alpendurada; Kaushik Guha; Rakesh Sharma; Tevfik F Ismail; Amy Cliffor πŸ“‚ Article πŸ“… 2011 πŸ› BioMed Central 🌐 English βš– 295 KB

## Background Cardiac resynchronization therapy (CRT) is an established treatment in advanced heart failure (HF). However, an important subset does not derive a significant benefit. Despite an established predictive role in HF, the significance of right ventricular (RV) dysfunction in predicting cl

MRI measurements of tumor size and pharm
MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy
✍ Hon J. Yu; Jeon-Hor Chen; Rita S. Mehta; Orhan Nalcioglu; Min-Ying Su πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 310 KB

## Abstract ## Purpose To investigate the value of using changes in three parameters (tumor size, transfer constant (K^trans^), and rate constant (k~ep~)) obtained after the first treatment‐cycle in predicting the final clinical response after two to four cycles of neoadjuvant anthracycline and cy

Predictors of response to therapy with t
Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome
✍ AndrΓ© Nazar; Gustavo Henrique Pereira; MΓ³nica Guevara; Marta MartΓ­n-Llahi; Marie πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 169 KB πŸ‘ 1 views

Terlipressin plus albumin is an effective treatment for type 1 hepatorenal syndrome (HRS), but approximately only half of the patients respond to this therapy. The aim of this study was to assess predictive factors of response to treatment with terlipressin and albumin in patients with type 1 HRS. T